CooperSurgical, Inc. Sustainability Profile
CooperSurgical, Inc., a leading name in women's health, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1990, the company has established itself within the medical device industry, focusing on innovative solutions for gynaecology and assisted reproductive technology. CooperSurgical's core offerings include a diverse range of products such as surgical instruments, fertility solutions, and diagnostic tools, all designed to enhance patient care and improve clinical outcomes. The company is recognised for its commitment to quality and innovation, positioning itself as a trusted partner for healthcare professionals. With a strong market presence and a reputation for excellence, CooperSurgical continues to make significant strides in advancing women's health globally.
DitchCarbon Score
How does CooperSurgical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CooperSurgical, Inc.'s score of 34 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CooperSurgical, Inc., headquartered in the US, currently does not have specific carbon emissions data available, as indicated by the absence of reported emissions figures. The company is a current subsidiary of The Cooper Companies, Inc., which may influence its climate commitments and emissions reporting. As of now, CooperSurgical has not established any documented reduction targets or initiatives related to carbon emissions. This lack of specific commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the absence of direct emissions data and reduction initiatives, it is essential for CooperSurgical to consider aligning with industry standards and frameworks, such as the Science Based Targets initiative (SBTi), to enhance its climate commitments and transparency in emissions reporting. This alignment could facilitate a more robust approach to managing and reducing carbon emissions in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 29,747,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 33,442,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - |
How Carbon Intensive is CooperSurgical, Inc.'s Industry?
How Carbon Intensive is CooperSurgical, Inc.'s Location?
CooperSurgical, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
CooperSurgical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
